Navigation Links
Breakthrough AffloVest now reimbursed by Medicare and private health insurance

AUSTIN, Texas, Sept. 10, 2013 /PRNewswire/ -- AffloVest, the first-ever portable High Frequency Chest Wall Oscillation (HFCWO) vest, is now approved for Medicare and private health insurance reimbursement.  Millions of Americans with respiratory disease can benefit from the innovative new airway clearance therapy vest that dramatically improves cough productivity and ease of breathing for chronic lung conditions such as severe Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis, Cystic Fibrosis and other related ailments.

The AffloVest recently earned FDA 510k market clearance in the United States and HCPCS reimbursement codes, according to David Shockley, President of International Biophysics Corporation (IBC), which developed and now markets the product in the U.S.

"With both Medicare and private health insurance reimbursement approved for AffloVest, this breakthrough technology is affordably available to millions of patients now," Shockley said.  "Other airway clearance vests tether the patient by an air hose to bulky machines that must be plugged into a wall.  The AffloVest is the market's first portable, battery-operated HFCWO vest. Users can move about freely – even travel – during treatments, or sit comfortably in any position, even while lying down," Shockley said. 

A recent clinical study — conducted by Dr. Konrad Schultz at the Bad Reichenhall Clinic in Munich, Germany — reveals that AffloVest substantially improves cough productivity, making it easier for patients to clear their lungs and breathe more easily through a productive cough.
The study concluded: 

"With every single patient, a dramatic improvement in cough productivity and bronchial secretion viscosity was observed in combination with the pulmonary and orthopedic regimen of care. It became fundamentally easier for the patients to cough out mucus, because of the more fluid secretions and more productive cough provided by the introduction of High Frequency Chest Wall Oscillation treatment with the AffloVest."

Weighing approximately 10 pounds, AffloVest is the lightest and most quiet device of its kind on the market today. Unlike other respiratory vest options, AffloVest provides adjustable levels of treatment intensity and multiple treatment modes. Doctors and patients can tailor their treatments to their needs, with settings that provide chest wall oscillation treatment on both the front and back of the vest.

The number of patients who can benefit from AffloVest is significant; for example, more than 10 million people in the United States currently live with COPD, according to the Centers for Disease Control.

AffloVest is available for Medicare and private health insurance reimbursement under the following Healthcare Common Procedure Coding System (HCPCS) code:

E0483 High Frequency Chest Wall Oscillation AffloVest is now available in five sizes – XS, S, M, L, XL – to serve both children and adults with chronic lung conditions.

AffloVest requires a physician's prescription and is available to U.S. patients through Durable Medical Equipment (DME) and Home Medical Equipment (HME) retailers.

About International Biophysics CorporationInternational Biophysics Corporation (IBC) is a privately held company that develops, manufactures, and sells a variety of complex medical devices. IBC's design and development capabilities include: CAD drawings/CAD interface, prototype development, initial product testing, tooling, mold design and manufacture, validation testing, and FDA submission. IBC is an ISO 13485 certified manufacturing company registered with the FDA, and is based in Austin, Texas. The distribution arm of IBC sells equipment and supplies ranging from centrifugal heart pumps, aortic punches, and blood suctioning wands. Its research and development team has also been involved in Portable Oxygen Concentrator development, dermatological laser devices, and other projects in various medical industries.Related Links: 

Media Contact:

Lisa Lawrencellawrence@salaspr.com512-426-4904

SOURCE International Biophysics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen Idecs Tecfidera to be a Breakthrough in the Treatment of Multiple Sclerosis
2. World Molecular Imaging Congress to Feature Scientific Breakthroughs in Molecular Multimodal Imaging Essential to Precision Medicine
3. Online Nominations for 2014 Breakthrough Prizes in Life Sciences are Open
4. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
5. Facebook and Twitter Drive Frenzy for Breakthrough "Anti-Aging Pill"
6. Tisch MS Researchers Announce Breakthrough in Disease Monitoring
7. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
8. AlignMeds Breakthrough Garment Technology Gets a YES from the FDA!
9. Orthocare Innovations Once Again Recognized for Top Honors for its Breakthrough Prosthetic Foot Ankle System
10. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
11. Zydus Pioneers a Breakthrough With LIPAGLYN, Indias First NCE to Reach the Market
Post Your Comments:
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology:
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
Breaking Medicine News(10 mins):